for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Invacare Corporation

IVC

Latest Trade

9.68USD

Change

-1.02(-9.53%)

Volume

703,076

Today's Range

9.53

 - 

10.86

52 Week Range

3.05

 - 

11.63

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
10.70
Open
10.77
Volume
703,076
3M AVG Volume
10.56
Today's High
10.86
Today's Low
9.53
52 Week High
11.63
52 Week Low
3.05
Shares Out (MIL)
33.66
Market Cap (MIL)
360.07
Forward P/E
-11.21
Dividend (Yield %)
0.47

Next Event

Invacare Corp at Stephens Investor Conference

Latest Developments

More

Invacare Posts Q3 Loss Per Share Of $0.24

Invacare Says Co Entered Master Services Agreement With Birlasoft Solutions, Affiliates Of CK Birla Group

Invacare Corporation Provides Business Update At Baird Global Healthcare Conference

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Invacare Corporation

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.

Industry

Medical Equipment & Supplies

Contact Info

1 Invacare Way

PO Box 4028

+1.440.3296000

http://www.invacare.com/

Executive Leadership

Matthew E. Monaghan

Chairman of the Board, President, Chief Executive Officer

Kathleen P. Leneghan

Chief Financial Officer, Senior Vice President

Anthony C. LaPlaca

Senior Vice President, General Counsel, Secretary

Ralf Ledda

Senior Vice President, General Manager - Europe, Middle East and Africa

Darcie L. Karol

Senior Vice President - Human Resources

Key Stats

2.00 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.0K

2017

1.0K

2018

1.0K

2019(E)

0.9K
EPS (USD)

2016

-1.410

2017

-1.930

2018

-1.320

2019(E)

-0.955
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.38
Price To Book (MRQ)
1.14
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
79.85
LT Debt To Equity (MRQ)
79.04
Return on Investment (TTM)
-5.38
Return on Equity (TTM)
-4.19

Latest News

Latest News

BRIEF-Invacare Corp Expands Board Size To Eight Members

* INVACARE CORP - ON MAY 17, BOARD EXPANDED BOARD SIZE TO EIGHT MEMBERS AND ELECTED PETRA DANIELSOHN-WEIL AS A DIRECTOR - SEC FILING Source text: (https://bit.ly/2rSA7Hj) Further company coverage:

BRIEF-Invacare Reports Q1 Adjusted Loss Per Share $0.35

* Q1 EARNINGS PER SHARE VIEW $-0.38 -- THOMSON REUTERS I/B/E/S

BRIEF-Invacare Corp Says CEO Matthew Monaghan's 2017 Total Pay Was $8.2 Mln Vs $4.1 Mln In 2016 – SEC Filing

* INVACARE CORP SAYS CEO MATTHEW E. MONAGHAN'S 2017 TOTAL COMPENSATION WAS $8.2 MILLION VERSUS $4.1 MILLION IN 2016 – SEC FILING Source text: (https://bit.ly/2JtAzCW) Further company coverage:

BRIEF-Invacare Says 2020 Goals Include Commitment To Achieve $100 Mln Of Annual Run-Rate EBITDA

* INVACARE - 2020 GOALS INCLUDE COMMITMENT TO ACHIEVE $100 MLN OF ANNUAL RUN-RATE EBITDA - SEC FILING Source text: (https://bit.ly/2Hlewxy) Further company coverage:

BRIEF-Invacare Appoints Kathleen Leneghan CFO

* INVACARE APPOINTS KATHLEEN LENEGHAN CHIEF FINANCIAL OFFICER

BRIEF-Invacare Corp Transfers Küschall Wheelchair Production From Switzerland To France

* INVACARE CORPORATION TRANSFERS KÜSCHALL WHEELCHAIR PRODUCTION FROM SWITZERLAND TO FRANCE

BRIEF-Invacare Corp Reports Q4 Loss Per Share $0.54

* ORATION ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2017

BRIEF-Invacare Says On Jan 3, FDA Notified Co That Its Unit Alber GMBH's Responses To Warning Letter Diclosed In Sept 2017 Are "Adequate" - SEC Filing

* INVACARE SAYS ON JAN 3, FDA NOTIFIED CO THAT ITS UNIT ALBER GMBH'S RESPONSES TO WARNING LETTER DICLOSED IN SEPT 2017 ARE "ADEQUATE" - SEC FILING

BRIEF-Invacare Announces North America Reduction In Force As Part Of Continued Cost Realignment

* INVACARE ANNOUNCES NORTH AMERICA REDUCTION IN FORCE AS PART OF CONTINUED COST REALIGNMENT

BRIEF-Invacare announces departure of Chief Financial Officer

* Invacare Corp - while co performs executive search to identify successor to Gudbranson, Kathleen P. Leneghan will assume role of interim CFO Source text for Eikon: Further company coverage:

BRIEF-Invacare says ‍Alber GMBH received warning letter from US food and drug administration​

* Invacare Corp - alber GMBH, a wholly owned subsidiary of Invacare Corporation, received warning letter from United States Food And Drug Administration

BRIEF-Invacare Q2 loss per share $0.72

* Q2 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

BRIEF-Invacare says will transfer production of wheelchairs to France

* Invacare - will transfer production of Invacare Rea manual wheelchairs from facility in Sweden to manufacturing facility in Fondettes, France by Jan. 2018

BRIEF-Invacare reaches new consent decree milestone

* Invacare says received notice from FDA that co has successfully satisfied requirements to resume full operations at its manufacturing facility in Elyria, Ohio

BRIEF-Invacare Corp announces closure of China manufacturing facility in line with strategic transformation

* Invacare Corporation announces closure of China manufacturing facility in line with strategic transformation Source text for Eikon: Further company coverage:

BRIEF-Invacare prices offering of $105 mln of convertible senior notes

* Invacare Corporation prices offering of $105 million aggregate principal amount of convertible senior notes

BRIEF-Invacare Q1 GAAP loss per share $0.52

* Q1 earnings per share view $-0.39 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Invacare says received notification from FDA that it accepted recent second certification report

* Invacare Corp says received notification from u.s.fda that it accepted recent second certification report by co's third-party expert relating to design control requirements

BRIEF-Invacare Corp Q4 adjusted loss per share $0.46 from continuing operations

* Invacare corporation announces financial results for the fourth quarter and full year ended december 31, 2016

BRIEF-Invacare Corp appoints Susan Alexander to its Board

* Invacare Corporation appoints Susan Alexander to board of directors Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up